Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to 0.23.

  • Cryo Cell International's Equity Ratio fell 5458.07% to 0.23 in Q3 2025 from the same period last year, while for Aug 2025 it was 0.23, marking a year-over-year decrease of 5458.07%. This contributed to the annual value of 0.2 for FY2024, which is 1980.54% down from last year.
  • Latest data reveals that Cryo Cell International reported Equity Ratio of 0.23 as of Q3 2025, which was down 5458.07% from 0.24 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Equity Ratio peaked at 0.08 during Q3 2021, and registered a low of 0.24 during Q2 2025.
  • Its 5-year average for Equity Ratio is 0.07, with a median of 0.02 in 2022.
  • Per our database at Business Quant, Cryo Cell International's Equity Ratio soared by 58167.96% in 2022 and then plummeted by 6548925.55% in 2024.
  • Over the past 5 years, Cryo Cell International's Equity Ratio (Quarter) stood at 0.07 in 2021, then tumbled by 134.06% to 0.02 in 2022, then plummeted by 626.05% to 0.17 in 2023, then fell by 19.81% to 0.2 in 2024, then decreased by 14.9% to 0.23 in 2025.
  • Its Equity Ratio was 0.23 in Q3 2025, compared to 0.24 in Q2 2025 and 0.23 in Q1 2025.